FDA says Boston Scientific initiates recall of stent for leg arteries

06/20/2011 | Wall Street Journal, The

The FDA said Boston Scientific has voluntarily pulled from the market its Innova self-expanding stent, which is designed to treat lesions in leg arteries, after receiving reports of deployment problems that might lead to vessel wall injury and emergency surgery, among other adverse events. Boston Scientific, which markets the device outside the U.S., already has informed consumers about the stent problem.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN